Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases
Background: The aspirin exacerbated respiratory disease (AERD) shows a prevalence of 7% among asthmatics and increases to 14% in patients with difficult to control asthma. Treatment includes the use of inhibitors of leukotriene receptor (), intranasal steroids, polypectomy, asthma management accordi...
Main Authors: | Julio César Cambray-Gutiérrez, Ulises Noel García-Ramírez, Leonel Gerardo Del Rivero-Hernández, Sean Alejandro Lozano-Martínez, Patricia López-Pérez, Aurora Alejandra Chávez-García |
---|---|
Format: | Article |
Language: | English |
Published: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2016-05-01
|
Series: | Revista Alergia México |
Subjects: | |
Online Access: | http://revistaalergia.mx/ojs/index.php/ram/article/view/151 |
Similar Items
-
Knowledge and attitudes about aspirin exacerbated respiratory disease among Ecuadorian physicians
by: Juan Carlos Calderón, et al.
Published: (2017-02-01) -
Aspirin-exacerbated respiratory disease. Case-based review
by: Karen Estefanía Hernández-Moreno, et al.
Published: (2018-04-01) -
Desensitization to darunavir in a pediatric patient
by: Julio César Cambray-Gutiérrez, et al.
Published: (2015-07-01) -
6 voices in 10 minutes: Aspirin in primary prevention
by: Carlos Buso
Published: (2020-11-01) -
The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)
by: Jonas Willian Spies, et al.